title: Medical treatment of antral gastrin cell hyperfunction: role of nonantisecretory therapy.
abstract: Antral G cell hyperfunction (AGCH) is a rare condition, often associated with severe duodenal ulcer disease poorly responsive to medical therapy. Up to now, no studies have been designed to investigate a possible role of medical treatment in the management of this syndrome. In this study we treated 9 AGCH patients with duodenal ulcer, unhealed with the prolonging standard doses of H2 antagonists (300 mg/day ranitidine or 800 mg/day cimetidine), with a nonantacid therapy, tripotassium dicitrato bismuthate (TDB). 6 out of 9 patients showed a complete healing after 8 weeks of treatment. The healing was irrespective to eradication of Campylobacter pylori. After 9 weeks' suspension of H2 blockers basal gastrin levels decreased significantly by 31.5%, whereas peak meal-stimulated levels, although decreased in 6 out 9 patients, were not significantly affected by the withdrawal of the H2 antagonists. Nonantisecretory therapy seems to be an efficacious alternative in the management of AGCH patients.
authors: Cattedra di Gastroenterologia, Università degli Studi La Sapienza, Roma, Italia.
authors: G
authors: G
authors: Delle Fave
authors: B
authors: B
authors: Annibale
authors: M
authors: M
authors: Puoti
authors: E
authors: E
authors: Giordano
authors: V
authors: V
authors: Corleto
authors: L
authors: L
authors: de Magistris
authors: A
authors: A
authors: Torsoli
mesh_terms: D000293:Adolescent; D000328:Adult; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use*; D002927:Cimetidine / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000188:drug therapy*; D004759:Enterochromaffin Cells / Q000378:metabolism; D005260:Female; D005744:Gastric Acid / Q000378:metabolism; D005755:Gastrins / Q000097:blood; D016481:Helicobacter Infections / Q000188:drug therapy; D016480:Helicobacter pylori / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds / Q000627:therapeutic use*; D011899:Ranitidine / Q000627:therapeutic use
chemical_list: D000897:Anti-Ulcer Agents; D005755:Gastrins; D009942:Organometallic Compounds; D002927:Cimetidine; D011899:Ranitidine; C002791:bismuth tripotassium dicitrate; D001729:Bismuth